| Literature DB >> 20004635 |
Ian G Barr1, John McCauley, Nancy Cox, Rod Daniels, Othmar G Engelhardt, Keiji Fukuda, Gary Grohmann, Alan Hay, Anne Kelso, Alexander Klimov, Takato Odagiri, Derek Smith, Colin Russell, Masato Tashiro, Richard Webby, John Wood, Zhiping Ye, Wenqing Zhang.
Abstract
Influenza vaccines form an important component of the global response against infections and subsequent illness caused in man by influenza viruses. Twice a year, in February and September, the World Health Organisation through its Global Influenza Surveillance Network (GISN), recommends appropriate influenza viruses to be included in the seasonal influenza vaccine for the upcoming Northern and Southern Hemisphere winters. This recommendation is based on the latest data generated from many sources and the availability of viruses that are suitable for vaccine manufacture. This article gives a summary of the data and background to the recommendations for the 2009-2010 Northern Hemisphere influenza vaccine formulation. (c) 2009 Elsevier Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2009 PMID： 20004635 DOI： 10.1016/j.vaccine.2009.11.043
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641